Lyell Wealth Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$648K Sell
7,515
-2,475
-25% -$218K 0.04% 153
2026
Q2
$782K Hold
9,990
– – 0.05% 137
2026
Q1
$866K Sell
9,990
-250
-2% -$24K 0.06% 124
2025
Q4
$984K Hold
10,240
– – 0.07% 118
2025
Q3
$975K Hold
10,240
– – 0.07% 121
2025
Q2
$893K Buy
+10,240
New +$868K 0.07% 126

Other funds holding MDT

Lyell Wealth Management's MDT Position: Q3 2026 in Review

Lyell Wealth Management reduced its Medtronic (MDT) stake by 25% in Q3 2026, selling an estimated $218K and leaving 7,515 shares worth $648K. The position accounts for 0.04% of the portfolio, ranked #153.

Lyell Wealth Management first reported a position in MDT in Q2 2025 and has held it in 6 quarters since. The position peaked at $984K in Q4 2025. 1,372 funds tracked by Wall St. Rank hold MDT as of Q3 2026.

  • Lyell Wealth Management held 7,515 shares of Medtronic worth $648K as of Q3 2026.
  • Lyell Wealth Management sold 2,475 Medtronic shares in Q3 2026, an estimated $218K.
  • Medtronic made up 0.04% of Lyell Wealth Management's portfolio in Q3 2026, its #153 holding.
  • Lyell Wealth Management first reported a position in Medtronic in Q2 2025 and has held it in 6 quarters since.
  • Lyell Wealth Management's Medtronic position peaked at $984K in Q4 2025.
  • 1,372 funds tracked by Wall St. Rank held Medtronic as of Q3 2026.

Based on Lyell Wealth Management's 13F filing for Q3 2026, filed 30 Oct 2026.